Nivacortol

Nivacortol (developmental code names WIN-27914 and NEBO-174; also known as nivazol and nivazole) is a synthetic glucocorticoid corticosteroid which was never marketed.[1][2][3][4]

Nivacortol
Clinical data
Other namesNivazol; Nivazole; WIN-27914; Novozola; NEBO-174; 2'-(4-Fluorophenyl)-2'-H-pregna-2,4-dien-20-yno(3,2-c)pyrazol-17-ol
Drug classCorticosteroid; Glucocorticoid
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard100.041.987
Chemical and physical data
FormulaC28H31FN2O
Molar mass430.567 g·mol−1
3D model (JSmol)

References
  1. J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 881–882. ISBN 978-1-4757-2085-3.
  2. http://adisinsight.springer.com/drugs/800019031
  3. Julio Alvarez-Builla; Juan José Vaquero; José Barluenga (2011). Modern Heterocyclic Chemistry: Vol. 1. John Wiley & Sons. pp. 649–. ISBN 978-3-527-33201-4.
  4. Honour JW, Sudan HL, Lovell G (1986). "The determination of nivacortol in plasma using HPLC". Biomed. Chromatogr. 1 (4): 151–4. doi:10.1002/bmc.1130010404. PMID 3506827.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.